Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MEETINGS - Better co-ordinating US public health agencies, in order to help speed the development of drugs, biologics and medical devices (US) November 2004:

This article was originally published in Clinica

Executive Summary

The US Health and Human Services (HHS) department has scheduled a public meeting for November 15 on Better co-ordinating US public health agencies, in order to help speed the development of drugs, biologics and medical devices. The information will be used by a high-level HHS taskforce that is currently preparing a report on the subject, which must be released by the end of 2004. The meeting will take place at HHS headquarters in Washington. For registration details, contact: Nancy Stanisic at the FDA: [email protected] or by fax: +1 301 443 9718.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT059940

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel